000			02019 a2200553 4500
005			20250516175005.0
264		0	_c20140515
008			201405s 0 0 eng d
022			_a1097-0215
024	7		_a10.1002/ijc.28521 _2doi
040			_aNLM _beng _cNLM
100	1		_aNeumann, Jennifer
245	0	0	_aThe natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints. _h[electronic resource]
260			_bInternational journal of cancer _cApr 2014
300			_a1991-2002 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aAtaxia Telangiectasia Mutated Proteins _xdrug effects
650	0	4	_aBenzofurans _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCheckpoint Kinase 1
650	0	4	_aCheckpoint Kinase 2 _xgenetics
650	0	4	_aDNA Damage _xdrug effects
650	0	4	_aHCT116 Cells
650	0	4	_aHT29 Cells
650	0	4	_aHep G2 Cells
650	0	4	_aHumans
650	0	4	_aJurkat Cells
650	0	4	_aLeukemia _xdrug therapy
650	0	4	_aMCF-7 Cells
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPlant Extracts _xpharmacology
650	0	4	_aProtein Biosynthesis _xdrug effects
650	0	4	_aProtein Kinases _xgenetics
650	0	4	_aRNA Interference
650	0	4	_aRNA, Small Interfering
650	0	4	_aS Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_acdc25 Phosphatases _xbiosynthesis
700	1		_aBoerries, Melanie
700	1		_aKöhler, Rebecca
700	1		_aGiaisi, Marco
700	1		_aKrammer, Peter H
700	1		_aBusch, Hauke
700	1		_aLi-Weber, Min
773	0		_tInternational journal of cancer _gvol. 134 _gno. 8 _gp. 1991-2002
856	4	0	_uhttps://doi.org/10.1002/ijc.28521 _zAvailable from publisher's website
999			_c23194697 _d23194697